These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 28619761)
1. Exhaled breath condensate biomarkers for the early diagnosis of lung cancer using proteomics. López-Sánchez LM; Jurado-Gámez B; Feu-Collado N; Valverde A; Cañas A; Fernández-Rueda JL; Aranda E; Rodríguez-Ariza A Am J Physiol Lung Cell Mol Physiol; 2017 Oct; 313(4):L664-L676. PubMed ID: 28619761 [TBL] [Abstract][Full Text] [Related]
2. Proteomics of exhaled breath condensate in stable COPD and non-COPD controls using tandem mass tags (TMTs) quantitative mass spectrometry: A pilot study. Sun C; Zhou T; Xie G; Fu S; Gao L; Liao J; Wu Y; Wang G J Proteomics; 2019 Aug; 206():103392. PubMed ID: 31129269 [TBL] [Abstract][Full Text] [Related]
3. CEA, SCC and NSE levels in exhaled breath condensate--possible markers for early detection of lung cancer. Zou Y; Wang L; Zhao C; Hu Y; Xu S; Ying K; Wang P; Chen X J Breath Res; 2013 Dec; 7(4):047101. PubMed ID: 24185583 [TBL] [Abstract][Full Text] [Related]
4. Exhaled Breath Condensate pH in Lung Cancer, the Impact of Clinical Factors. Bikov A; Lazar Z; Gyulai N; Szentkereszty M; Losonczy G; Horvath I; Galffy G Lung; 2015 Dec; 193(6):957-63. PubMed ID: 26260979 [TBL] [Abstract][Full Text] [Related]
5. Proteomics as a method for early detection of cancer: a review of proteomics, exhaled breath condensate, and lung cancer screening. Conrad DH; Goyette J; Thomas PS J Gen Intern Med; 2008 Jan; 23 Suppl 1(Suppl 1):78-84. PubMed ID: 18095050 [TBL] [Abstract][Full Text] [Related]
6. Exhaled breath condensate for lung cancer protein analysis: a review of methods and biomarkers. Hayes SA; Haefliger S; Harris B; Pavlakis N; Clarke SJ; Molloy MP; Howell VM J Breath Res; 2016 Jul; 10(3):034001. PubMed ID: 27380020 [TBL] [Abstract][Full Text] [Related]
7. Comparative proteomic analysis of exhaled breath condensate between lung adenocarcinoma and CT-detected benign pulmonary nodule patients. Ma L; Xiu G; Muscat J; Sinha R; Sun D; Xiu G Cancer Biomark; 2022; 34(2):163-174. PubMed ID: 34334381 [TBL] [Abstract][Full Text] [Related]
8. Mass Spectrometry Analysis of the Exhaled Breath Condensate and Proposal of Dermcidin and S100A9 as Possible Markers for Lung Cancer Prognosis. Núñez-Naveira L; Mariñas-Pardo LA; Montero-Martínez C Lung; 2019 Aug; 197(4):523-531. PubMed ID: 31115649 [TBL] [Abstract][Full Text] [Related]
9. Proteomics of exhaled breath condensate in lung cancer and controls using data-independent acquisition (DIA): a pilot study. Ma L; Muscat JE; Sinha R; Sun D; Xiu G J Breath Res; 2021 Jan; 15(2):. PubMed ID: 33271515 [TBL] [Abstract][Full Text] [Related]
10. Mass spectrometry based proteome profiling of the exhaled breath condensate for lung cancer biomarkers search. Zakharova N; Kozyr A; Ryabokon AM; Indeykina M; Strelnikova P; Bugrova A; Nikolaev EN; Kononikhin AS Expert Rev Proteomics; 2021 Aug; 18(8):637-642. PubMed ID: 34477466 [TBL] [Abstract][Full Text] [Related]
11. Proteomic characterization of human exhaled breath condensate. Lacombe M; Marie-Desvergne C; Combes F; Kraut A; Bruley C; Vandenbrouck Y; Chamel Mossuz V; Couté Y; Brun V J Breath Res; 2018 Feb; 12(2):021001. PubMed ID: 29189203 [TBL] [Abstract][Full Text] [Related]
12. Non-invasive breath analysis of pulmonary nodules. Peled N; Hakim M; Bunn PA; Miller YE; Kennedy TC; Mattei J; Mitchell JD; Hirsch FR; Haick H J Thorac Oncol; 2012 Oct; 7(10):1528-33. PubMed ID: 22929969 [TBL] [Abstract][Full Text] [Related]
13. Determining the presence of asthma-related molecules and salivary contamination in exhaled breath condensate. Cruickshank-Quinn C; Armstrong M; Powell R; Gomez J; Elie M; Reisdorph N Respir Res; 2017 Apr; 18(1):57. PubMed ID: 28403875 [TBL] [Abstract][Full Text] [Related]
14. Advances in proteomics methods for the analysis of exhaled breath condensate. Yoo EJ; Kim JS; Stransky S; Spivack S; Sidoli S Mass Spectrom Rev; 2024; 43(4):713-722. PubMed ID: 38149478 [TBL] [Abstract][Full Text] [Related]
15. Bioanalysis of underivatized amino acids in non-invasive exhaled breath condensate samples using liquid chromatography coupled with tandem mass spectrometry. Konieczna L; Pyszka M; Okońska M; Niedźwiecki M; Bączek T J Chromatogr A; 2018 Mar; 1542():72-81. PubMed ID: 29477235 [TBL] [Abstract][Full Text] [Related]
16. Exhaled breath condensate biomarkers for lung cancer. Campanella A; De Summa S; Tommasi S J Breath Res; 2019 Aug; 13(4):044002. PubMed ID: 31282387 [TBL] [Abstract][Full Text] [Related]
17. Increased levels of exhaled sICAM1, sVCAM1, and sE-selectin in patients with non-small cell lung cancer. Zhou F; Chen J; Tao G; Zhu M; Xie W; Cao X Respir Med; 2014 Nov; 108(11):1670-6. PubMed ID: 25179787 [TBL] [Abstract][Full Text] [Related]
18. Development of an accurate and sensitive method for lactate analysis in exhaled breath condensate by LC MS/MS. Jackson TC; Zhang YV; Sime PJ; Phipps RP; Kottmann RM J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep; 1061-1062():468-473. PubMed ID: 28822945 [TBL] [Abstract][Full Text] [Related]
19. Bronchoalveolar Lavage Proteomics in Patients with Suspected Lung Cancer. Carvalho AS; Cuco CM; Lavareda C; Miguel F; Ventura M; Almeida S; Pinto P; de Abreu TT; Rodrigues LV; Seixas S; Bárbara C; Azkargorta M; Elortza F; Semedo J; Field JK; Mota L; Matthiesen R Sci Rep; 2017 Feb; 7():42190. PubMed ID: 28169345 [TBL] [Abstract][Full Text] [Related]
20. Extraction and characterization of exosomes from the exhaled breath condensate and sputum of lung cancer patients and vulnerable tobacco consumers-potential noninvasive diagnostic biomarker source. Bano A; Yadav P; Sharma M; Verma D; Vats R; Chaudhry D; Kumar P; Bhardwaj R J Breath Res; 2024 Jul; 18(4):. PubMed ID: 38988301 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]